Abbott India Finance Director Jyoti Saraph to resign
Mumbai: Abbott India has announced the resignation of Jyoti Saraph, Director Finance with effect from the close of business hours of June 23, 2025.
"Jyoti Saraph, Director Finance, has tendered her resignation from employment of the Company with effect from the close of business hours of June 23, 2025, to pursue opportunities outside the Company," Abbott stated in a BSE filing.
Pursuant to her resignation, she will also cease to be the Senior Management Personnel of the Company effective the said date.
Jyoti has over 25 years of rich and diverse experience across industries in India and the USA in various finance and accounting functions. Jyoti joined Abbott through the Solvay acquisition and has worked across Abbott's Pharma, Nutrition and Corporate Financial Services verticals for the last 12 years. Jyoti worked for telecom product startups in the USA before returning to India. She led the accounting function of Solvay Pharma India.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.